LicianPro

STANDARD BIOTOOLS INC. ·

LAB 8-K 2026-09-30

STANDARD BIOTOOLS INC. (LAB) 8-K dated 2026-09-30 — accession 0001140361-26-038110.

STANDARD BIOTOOLS INC. (LAB) is a medical devices company listed on NASDAQ.

STANDARD BIOTOOLS INC. filed a 8-K on 2026-09-30. Accession 0001140361-26-038110.

This 8-K covers: Material agreement (Item 1.01), Agreement ended (Item 1.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LAB revenue for 2025-12-31 was $85.3M. Net income was -$74.9M. Revenue was down 51.1% from 2024-12-31 to 2025-12-31. LAB currently screens at market cap $317.1M.

Not investment advice. The LAB SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr